Detalhe da pesquisa
1.
Preclinical Development of PNT6555, a Boronic Acid-Based, Fibroblast Activation Protein-α (FAP)-Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors.
J Nucl Med;
65(1): 100-108, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38050111